arrow
H

Hitomi Ajimizu

kyoto university
H指数:10
被引数:351

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical significance of inhaled COPD therapy in advanced or recurrent non-small cell lung cancer in the immune checkpoint inhibitor era: a multicenter retrospective cohort study

免疫检查点抑制剂时代吸入性COPD疗法在晚期或复发性非小细胞肺癌中的临床意义:一项多中心回顾性队列研究

2026-08-180
OAAI
Resistance mechanisms and efficacy of first-line (1L) alectinib in patients (pts) with ALK-rearranged non-small cell lung cancer (ALK plus NSCLC): Second interim analysis of ALCURE

ALK易位非小细胞肺癌(ALK plus NSCLC)患者中,一线(1L)阿来替尼的耐药机制与疗效:ALCURE研究的第二次中期分析

2024-12-010
PRE
Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study
2021-05-292
OAAI
PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade

PD-L1多态性预测PD-1阻滞治疗的晚期非小细胞肺癌患者的生存结果

2021-02-0114
PREAI
ABCC11 is involved in resistance to alectinib
2019-07-010
PRE
Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
2019-01-0242
OAAI